16 Results for "

FXIIa

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "FXIIa" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-P99631
CAS No.: 2162134-62-3
Synonyms: CSL312

Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-163348
Target:  

Factor Xa Thrombin

Research Areas:  

Cardiovascular Disease

FXIIa-IN-4 (compound 22) is a potent, selective human FXIIa inhibitor with the IC50 of 0.032 μM, 0.30 μM, >50 μM for FXIIa, thrombin and FXIa, respectively. FXIIa-IN-4 can be used for study of anticoagulant .
loading...
    loading...
Cat. No.: HY-P99415
CAS No.: 2098724-83-3
Synonyms: MAA868

Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Abelacimab (MAA868) is a fully human IgG1 monoclonal antibody that binds with high affinity to the catalytic structural domain of FXI and locks it in the zymogen conformation, thereby preventing its activation by FXIIa or thrombin. Abelacimab can be used in thromboembolic disease studies .
loading...
    loading...
Cat. No.: HY-P4331
CAS No.: 113865-85-3
Research Areas:  

Cardiovascular Disease

Boc-Gln-Gly-Arg-AMC is a fluorogenic substrate for kallikrein (PKa), coagulation factor XIIa (FXIIa) and coagulation factor XIa (FXIa). Boc-Gln-Gly-Arg-AMC enables fluorescence-based activity assays for PKa, FXIIa and FXIa .
loading...
    loading...
Cat. No.: HY-175735
CAS No.: 2563884-39-7
Target:  

Factor XI

Research Areas:  

Cardiovascular Disease

Factor XI-IN-2 is a Factor XI activation inhibitor with an IC50 of 20 nM. Factor XI-IN-2 does not directly inhibit the enzymatic activity of FXIa, but specifically binds to the FXI enzyme precursor and allosterically inhibits the process by which it is activated by FXIIa. Factor XI-IN-2 inhibits thrombosis in the rabbit arteriovenous (AV) shunt thrombosis model. Factor XI-IN-2 can be used for the study of antithrombus .
loading...
    loading...
Cat. No.: HY-149397
CAS No.: 3052551-17-1
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

FXIIa-IN-1-IN-2 (Compound 21) is a Factor XIIa inhibitor (Ki app: 62.2 nM). FXIIa-IN-1-IN-2 can be used for research of thrombosis .
loading...
    loading...
Cat. No.: HY-152150
CAS No.: 2866508-00-9
Target:  

Ser/Thr Protease

Research Areas:  

Metabolic Disease

Thrombin inhibitor 7 is a potent FXIIa inhibitor with IC50 values of 28 nM, >132 µM for FXIIa and FXIa, respectively. Thrombin inhibitor 7 shows low cytotoxicity .
loading...
    loading...
Cat. No.: HY-149396A
CAS No.: 3052551-20-6
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

FXIIa-IN-1 hydrochloride is the hydrochloride of FXIIa-IN-1 (HY-149396). FXIIa-IN-1 (Compound 22) is a Factor XIIa inhibitor (Ki app: 97.8 nM). FXIIa-IN-1 can be used for research of thrombosis .
loading...
    loading...
Cat. No.: HY-163347
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

FXIIa-IN-3 (Compound 8) is a potent and selective Factor XIIa (FXIIa) inhibitor, with an IC50 of 0.045 μM. FXIIa-IN-3 also exhibits a substantial margin of selectivity against related serine proteases, including FXIa, FXa, and FIXa. FXIIa-IN-3 can be used for the research of thromboembolic diseases .
loading...
    loading...
Cat. No.: HY-162646
CAS No.: 3047411-80-0
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

FXIIa-IN-5 (Compound 4J) is an orally active, selective inhibitor for factor XIIa (FXIIa), with IC50 of 21 nM. FXIIa-IN-5 inhibits the intrinsic coagulation pathways, and exhibits anti-inflammatory and antithrombotic activity in Carrageenan (HY-125474)-induced mice thrombosis models. FXIIa-IN-5 exhibits moderate pharmacokinetic characteristics and slightly toxicity (at 100 mg/kg) .
loading...
    loading...
Cat. No.: HY-184008
CAS No.: 3107571-66-1
Target:  

Ser/Thr Protease

Research Areas:  

Inflammation/Immunology

FXIIa-IN-6 is a potent, selective, and irreversible covalent inhibitor of Factor XIIa (FXIIa) with an IC50 of 2 nM. FXIIa-IN-6 exhibits ≥2,500-fold selectivity over related serine proteases. FXIIa-IN-6 exhibits favorable anticoagulant and anti-inflammatory activities and can be used in sepsis research .
loading...
    loading...
Cat. No.: HY-149396
CAS No.: 3052551-19-3
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

XIIa-IN-1-IN-3 (Compound 22) is a Factor XIIa inhibitor (Ki app: 97.8 nM). XIIa-IN-1-IN-3 can be used for research of thrombosis .
loading...
    loading...
Cat. No.: HY-P10860
CAS No.: 2853605-24-8
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

cMCoFx1 is a potent and selective FXIIa cyclic peptide inhibitor. cMCoFx1 has high binding affinity (KD: 900 pM) and inhibitory activity (Ki: 370 pM) for FXIIa. cMCoFx1 can effectively inhibit endogenous clotting pathways, and cMCoFx1 is stable in serum and non-cytotoxic .
loading...
    loading...
Cat. No.: HY-P4333
CAS No.: 73554-94-6
Target:  

Fluorescent Dye

Research Areas:  

Cardiovascular Disease

Boc-Glu(OBzl)-Gly-Arg-AMC is a fluorogenic substrate for factors IXa and XIIa. The cleavage of the amide bond between arginine and the methylcoumarin amide group releases fluorescent 7-Amino-4-methylcoumarin (HY-D0027) .
loading...
    loading...
Cat. No.: HY-P991994

Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

REGN9533 is a human-derived monoclonal antibody against FXII/FXIIa with high affinity for FXII, FXIIa and β-FXIIa. REGN9533 selectively inhibits the intrinsic coagulation pathway and FXIIa-driven plasma kallikrein activity. REGN9533 is applicable to FXIIa-related diseases such as thrombosis and hereditary angioedema .
loading...
    loading...
Cat. No.: HY-P991993

Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

AB054 is a humanized monoclonal antibody targeting factor XII (FXII). AB054 inhibits FXII activation and FXIIa activity through specific binding to the catalytic domain of FXII, and exerts antithrombotic effects in a concentration-dependent manner. AB054 can be used in studies related to thrombosis .
loading...
    loading...
  • 1